Increase in the prevalence of diabetes globally, have resulted in growing demand for the adoption of diabetes related devices and treatments.
The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks.
Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:
Decision-making process and customer buying pattern.
Reimbursement landscape and diabetes-related expenditure per person.
Treatment options and related costs across countries.
Comparative prevalence of diabetes.
Get your copy or request a free sample of the report Disease Demographics for Diabetes Type 1 and Type 2, 2023, compiled and published by Grand View Research.
Disease Demographics for Diabetes Type 1 and Type 2 Report Scope
Attribute | Details |
Patient Demographics | - Total Population
- People with diabetes
- People with undiagnosed diabetes
- Deaths attributable to diabetes
|
Treatment Options | - Type 1 Diabetes
- Insulin
- Diet
- Blood glucose monitoring
- Type 2 Diabetes
- Oral Medications
- Diet
- Exercise
- Blood glucose monitoring
- Insulin
|
Treatment Cost Per Patient | - Total diabetes-related health expenditure, USD Million
- Diabetes-related health expenditure per person, USD
|
Quality of Life | - Disability-adjusted life years (DALYs)
|
Comorbidity Analysis | - Diabetic foot ulcer
- Cardiovascular disease (CVD)
- Diabetic retinopathy
- Diabetic neuropathy
- Diabetic nephropathy
|
Reimbursement Differences | - Coverage for Medicare and Medicaid
- Type 1 Diabetes
- Type 2 Diabetes
|
Regions | - North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
|
Related Reports:
Diabetes Associated Ophthalmic Treatment Market Size, Share Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
